V28-77217-12675
4 vaccinations
2 coded responses
40 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 722 / AR
- Registered
- 2020-12-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
W7G-27771-29360
Child or adolescent in my care · Male · 2022-07-04
Timeline
-
2020-12-18
Registered in v-safe
-
2020-12-18
Dose 1 — Pfizer-BioNTech
- 2020-12-18
- 2020-12-19
-
2020-12-20
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fever · Fatigue or tiredness, Nausea, DiarrheaAdult check-in
- 2020-12-21
- 2020-12-22
- 2020-12-27
- 2021-01-01
-
2021-01-08
Dose 2 — Pfizer-BioNTech
-
2021-01-09
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-09
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-22
- 2021-01-29
- 2021-02-05
- 2021-02-12
- 2021-02-19
-
2021-04-11
Survey response — 3 months, dose 2MedDRA: Nasopharyngitis — Feeling: GoodFree text: Cold/URIMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-09
-
2021-09-25
Dose 3 — Pfizer-BioNTech
- 2021-09-28
- 2021-10-01
- 2021-10-04
- 2021-10-09
- 2021-10-16
- 2021-10-23
- 2021-10-30
- 2021-11-06
- 2021-12-25
- 2022-03-26
- 2022-09-25
-
2022-09-30
Dose 4 — Pfizer-BioNTech
- 2022-10-05
- 2022-10-06
- 2022-10-07
- 2022-10-14
- 2022-10-23
-
2022-10-28
Survey response — day 28, dose 4MedDRA: Infection, Influenza — Feeling: Fair · Be unable to work or attend schoolFree text: Flu infectionMedDRA releases: 2024-11 · check-in free text available
- 2022-11-11
- 2023-04-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech | |
| 3 | 2021-09-25 | Pfizer-BioNTech | No |
| 4 | 2022-09-30 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-09 | priority 2/3 |
Free text
Release 7 — 3 months, dose 2
Symptoms: Cold/URI
Release 12 — day 28, dose 4
Symptoms: Flu infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Infection | · | · | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release